Curis Inc

CRIS XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

9.5M

Short interest (Jul 15)

5.4%

Net Short (Jul 27 ): 0.1%

Borrow Fee

6.32%

↓ 30.0%

Available Shares

200K

↑ 1612.7%

Price Chart

Company Overview

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001108205

Asset Type: CS

Market Data

Market Cap: $9,530,287

Employees: 24

Status: Active

Short Interest

Current Borrow Fee 6.32%

Range: 6.00% - 6.36%

Available Shares 200K

Range: 100K - 200K

Recent Changes

Fee Change: ↓ 2.0%

Available Change: ↓ 97.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime